Characteristics and limitations of national antimicrobial surveillance according to sales and claims data.

ABSTRACT:

Purpose

Antimicrobial use (AMU) is estimated at the national level by using sales data (S-AMU) or insurance claims data (C-AMU). However, these data might be biased by generic drugs that are not sold through wholesalers (direct sales) and therefore not recorded in sales databases, or by claims that are not submitted electronically and therefore not stored in claims databases. We evaluated these effects by comparing S-AMU and C-AMU to ascertain the characteristics and limitations of each kind of data. We also evaluated the interchangeability of these data by assessing their relationship.

Methods

We calculated monthly defined daily doses per 1,000 inhabitants per day (DID) using sales and claims data from 2013 to 2017. To assess the effects of non-electronic claim submissions

SUBMITTER: Kusama Y 

PROVIDER: S-EPMC8112693 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature